Docket Room
SR 201·KY·senate

A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.

Passed One ChamberFiled Mar 26, 2026
Latest Action

adopted by voice vote

Apr 1, 2026

Summary

The Senate passed a resolution encouraging state policymakers to examine, design, and adopt economic policies that would attract biopharma companies to Kentucky. It highlights the potential for high‑paying jobs and urges incentives such as tax credits, grants, and dedicated funding pools. The measure is symbolic, aiming to keep talent and research in the state.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SR 201 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice